Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIONA: Finerenone in Children With Chronic Kidney Disease and Proteinuria
NCT05196035Phase 3Active, not recruiting
- Sponsor
- Bayer
- Start
- Mar 2022
- Primary completion
- Apr 2027
- Countries
- 32
01
Overview
A Phase 3 trial of finerenone in chronic kidney disease (CKD), proteinuria, sponsored by Bayer. Started Mar 2022; status: active, not recruiting.
02
Drugs
finerenone
03
Conditions
chronic kidney disease (CKD)proteinuria
Beyond the preview
Go deeper on NCT05196035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05196035.